Subsequently, we found that overexpression of SAR1 significantly prevented abiraterone-induced cell death (Figure 5D), suggesting that the tumor-suppressive effect of CYP17A1 inhibition is mediated by the downregulation of SAR1a/b. Here, SAR1A is linked to neoplasm.